Inhibition of low density lipoprotein oxidation by myrigalone B, a naturally occurring flavonoid

Pharmacology and Toxicology

Volumn 78, Issue 3, 1996, Pages 143-146

  Mathiesen, Liv ^a   Malterud, Karl Egil ^a   Nenseter, Marit S ^a   Sund, Reidar Bredo ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; FLAVONOID; LOW DENSITY LIPOPROTEIN; MYRIGALONE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOSE RESPONSE; LIPID PEROXIDATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RABBIT;

ANIMALIA; GALE; MYRICA GALE; ORYCTOLAGUS CUNICULUS;

EID: 0029918399     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00195.x     Document Type: Article

References (26)

1. Budavari, S. (Ed.): The Merck Index, 11. ed. Merck, Rahway, NJ, 1989, p. 1579.
2. Esterbauer, H., G. Striegl, H. Puhl, S. Oberreither, M. Rotheneder, M. El-Saadani & G. Jürgens: The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann. N. Y. Acad. Sci. 1989a, 570, 254-267.
3. Esterbauer, H., G. Striegl, H. Puhl & M. Rotheneder: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 1989b, 6, 67-75.
4. Esterbauer, H., M. Dieber-Rotheneder, G. Waeg, G. Striegl & G. Jürgens: Biochemical, structural, and functional properties of oxidised low-density lipoprotein. Chem. Res. Toxicol. 1990. 3, 77-92.
5. Esterbauer, H. & G. Jürgens: Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr. Opin. Lipidol. 1993, 4, 114-124.
6. Frankel, E. N., J. Kanner, J. B. German, E. Parks & J. E. Kinsella: Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341, 454-457.
7. Jessup, W., S. M. Rankin, C. V. de Whalley, J. R. S. Hoult & D. S. Leake: α-Tocopherol consumption during low-density-lipoprolein oxidation. Biochem. J. 1990, 265, 399-405.
8. Kashyap, M. L., B. A. Hynd & K. Robinson: A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. J. Lipid Res. 1980, 21, 491-495.
9. Livrea, M. A., L. Tesoriere, A. Bongiorno, A. M. Pintaudi, M. Ciaccio & A. Riccio: Contribution of vitamin A to the oxidation resistance of human low density lipoprotein. Free Rad. Biol. Med. 1995, 18, 401-409.
10. Malterud, K. E.: C-Methylated dihydrochalcones from Myrica gale fruit exudate. Acta pharm. nord. 1992, 4, 65-68.
11. Malterud, K. E., O. H. Diep & R. B. Sund: C-Methylated dihydrochalcones from Myrica gale L.: Effects as antioxidants and scavengers of 1,1-diphenyl-2-picrylhydrazyl. Pharmacology & Toxicology 1996, 78, 111-116.
12. Mangiapane, H., J. Thomson, A. Salter, S. Brown, G. D. Bell & D. A. White: The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochem. Pharmacol. 1992, 43, 445-450.
13. Mathiesen, L., K. E. Malterud & R. B. Sund: Antioxidant activity of fruit exudate and C-methylated dihydrochalcones from Myrica gale L. Planta Med. 1995, 61, 515-518.
14. Négre-Salvayre, A. & R. Salvayre: Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Rad. Biol. Med. 1992, 12, 101-106.
15. Nenseter, M., O. Gudmundsen, K. E. Malterud, T. Berg & C. A. Drevon: Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification. Biochim. Biophys. Acta 1994, 1213, 207-214.
16. Nenseter, M., B. Halvorsen, Ø. Rosvold, A. C. Rustan & C. Drevon: Paracetamol inhibits copper ion induced-, azo compound initiated-and mononuclear cell-mediated oxidative modification of low density lipoprotein. Arterioscler. Thromh. Vase. Biol. 1995, 15, 1338-1344.
17. Noble, R. P.: Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 1968, 9, 693-700.
18. Parthasarathy, S., S. G. Young, J. L. Witztum, R. C. Pittman & D. Steinberg: Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 1986, 77, 641-644.
19. Pierpoint, W. S.: Flavonoids in human diet. Progr. Clin. Biol. Res. 1968, 213, 125-140.
20. Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362, 801-809.
21. Sparrow, C. P., T. W. Doebber, J. Olszewski, M. S. Wu, J. Ventre, K. A. Stevens & Y. Chao: Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J. Clin. Invest. 1992, 89, 1885-1891.
22. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo & J. L. Witztum: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 1989, 320, 915-924.
23. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum & D. Steinberg: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 1984, 81, 3883-3887.
24. Stocker, R., V. W. Bowry & B. Frei: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does αtlocopherol. Proc. Natl. Acad. Sci. USA 1991, 88, 1646-1650.
25. Suzukawa, M., T. Ishikawa, H. Yoshida & H. Nakamura: Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J. Amer. Coll. Nutr. 1995, 14, 46-52.
26. Uyar, T., K. E. Malterud & T. Anthonsen: Two new dihydrochalcones from Myrica gale. Phytochemistry 1978, 17, 2011-2013.